Topic: 🌟🌟[ANN][ICO] CURAIZON - Improving Healthcare, Reducing Costs, Saving lives!🌟 - page 5. (Read 2434 times)

Ico whose projects in the health world like me already a lot, but among them most of the success. and get a lot of support from the investors, yes hope hope this one project also gained the same success with the previous project, because usual project like this have very good prospect.success for this project

the concept of health is indeed very precious and we should support, but my experience with the concepts of project health less sought after by investors. I hope the team can promote the project more unique and attractive again so that the project was much sought after by investors.

Mr. Durzada is the advantages of this platform.
In addition to this, Curaizon provides national health services, and this platform collects full anonymous data on how and when patients use drugs.
Great concept for the health of the world population.

CURAIZON improves health, reduces costs, and saves lives. all services are supported with Cura tokens. This token allows the token holder to access exclusive and anonymous medical data in blockchain.

What is the stage of your ICO?I feel that your project has many supporters, which is very popular and impressive.
I will keep following your development progress

thank you, for recommending this project

Do I understand correctly that you already have or will have the material and technical base and you clearly know how to grow further in a competitive environment ?.

Curaizon will increase its severity by creating Cura Token Utility Tokens (CTKN). this token allows the token holder to access our exclusive and anonymous medical data in blockchain.

Hello Team  

We just added Curaizon to  CryptoSlate's ICO database.

Check it out here —> https://cryptoslate.com/coins/curaizon/




If you need to edit any information about your ICO, please go to Curaizon ICO page on our website and click "Suggest an Edit". Feel free to contact us via https://cryptoslate.com/contact/ if you have any questions. Thank you.

Invest in the CURAIZON project is promising. If large investors come this is good. Small private investors are even better. They will complement each other and the token will be more stable. Tell me, please, such question, whether dividends will be added to holders of tokens of the given project?

Thanks for the question. This is very important, so I’m very happy to elaborate.

We are already a very real company – we’ve been in existence as a conceptual development since 2012 and we were incorporated in 2015. I think our materials go a long way to answering your questions and I encourage you to read our whitepaper specifically, but I’m happy to give you some answers here. Drug non-adherence is the greatest cause of waste within healthcare today, so by addressing this we can deliver several things:
1, improved patient outcomes
2, Reduction in waste that costs more than $700B each year
3, Data that will help us drive improvements across the healthcare spectrum
4, Better research and better use of drugs
In terms of tools we are able to provide to the pharmaceutical industry, we can deliver data! Currently, R&D is hampered by a lack of data on efficacies of drugs (adherence etc.), access to the right patients for clinical trials and information related to comorbidity (patients with multiple diseases and therefore multiple drugs and their effects)
With respect to your community question, it is imperative that we engage not only the patients, but also their families. By making them stakeholder in their own care, we can reduce the need for unnecessary intervention by the health services, thus saving money and resources that are needed elsewhere. Our technologies do precisely this.
Drug non-adherence is the 4th biggest killer and without our technologies this will only increase. We can make a real difference to people’s lives and, at the same time, save billions of dollars. Supporting our ICO will drive real change that will benefit millions of patients worldwide. Thanks.

The project has very nice concept and idea.  Improving the healthcare and saving lives is very excellent and impressive though but hopefully this project will be a realistic one.  I am curious, what kind of tools that you are providing to the pharmaceutical industries that would really cater the patient needs?  Support from the community is really needed.

Medicinal subjects are very popular and promising. But, drugs can not be created without agreement with state organizations.

Yes @daviszayn,
It’s the 4th leading cause of death and costs over €600 Billion per year in avoidable waste. They team at Curaizon are pioneering drug adherence technologies that have been shown to improve adherence by between 30-37%.

Unfortunately, far too many people fail to take their medicatons properly and the resultng personal and fnancial costs are staggering.

Medicines are our most cost effective health intervention and represent the first line of defense against chronic and long-term conditions. Unfortunately, far too many people fail to take their medications properly and the resulting personal and financial costs are staggering. Despite a worldwide recognition of the seriousness of the issue (also called drug non-adherence), there has been no significant change for the last 30 years.

• Worldwide drug non-adherence results in approximately $700 billion in additional healthcare costs.
• Pharmaceutical companies lose more than $630 billion in revenue annually to patient non-adherence and the amount lost is increasing by 13% per year.

CuraServe[tm] is a complete healthcare ecosystem that improves drug adherence and brings game-changing benefits to patients and healthcare providers. We use a series of outreach tools and messages, supported by predictive modeling and behavioural analytics, to increase the rate of drug adherence. As our CuraServe[tm] solution helps patients, also generating a vast amount of patient data. That data is then anonymized and made available through CuraData[tm]. The only way that pharmaceutical companies, academics and researchers can access this data by purchasing CuraTokens[tm].

Our data is the first-of-its-kind insight into real-time patient behavior and adherence. CuraData[tm] will finally give the health and pharmaceutical industries the tools they have been looking for to bring about the change patients need. Our value-based approach to a simple, accessible, yet valuable exchange of data and analysis will revolutionize healthcare.

Healthcare is changing forever and CuraServe[tm] stands at the cutting edge of this transformation.

Curaizon[tm] is the UK-based company that has developed CuraServe[tm].



The total number of potential users of our platform include all of the patients covered by national health services across the world. This is a total of 1.4 Billion patients and growing.

• Better Lives
• Better Research
• Better Healthcare
• Money Saved

CuraToken[tm](CTKN) is an EIP-20 Ethereum-based utility token which can be used to access medical adherence data via Curaizon[tm] CuraData[tm] platform.